These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12165561)

  • 1. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism.
    Challis BG; Pritchard LE; Creemers JW; Delplanque J; Keogh JM; Luan J; Wareham NJ; Yeo GS; Bhattacharyya S; Froguel P; White A; Farooqi IS; O'Rahilly S
    Hum Mol Genet; 2002 Aug; 11(17):1997-2004. PubMed ID: 12165561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans.
    Krude H; Biebermann H; Luck W; Horn R; Brabant G; Grüters A
    Nat Genet; 1998 Jun; 19(2):155-7. PubMed ID: 9620771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance.
    Lee YS; Challis BG; Thompson DA; Yeo GS; Keogh JM; Madonna ME; Wraight V; Sims M; Vatin V; Meyre D; Shield J; Burren C; Ibrahim Z; Cheetham T; Swift P; Blackwood A; Hung CC; Wareham NJ; Froguel P; Millhauser GL; O'Rahilly S; Farooqi IS
    Cell Metab; 2006 Feb; 3(2):135-40. PubMed ID: 16459314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic mutation screening of the pro-opiomelanocortin gene: identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremes.
    Hinney A; Becker I; Heibült O; Nottebom K; Schmidt A; Ziegler A; Mayer H; Siegfried W; Blum WF; Remschmidt H; Hebebrand J
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3737-41. PubMed ID: 9768693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation in the proopiomelanocortin (POMC) gene of a Hispanic child: metformin treatment shows a beneficial impact on the body mass index.
    Hilado MA; Randhawa RS
    J Pediatr Endocrinol Metab; 2018 Jul; 31(7):815-819. PubMed ID: 29858905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel missense mutation in the signal peptide of the human POMC gene: a possible additional link between early-onset type 2 diabetes and obesity.
    Mencarelli M; Zulian A; Cancello R; Alberti L; Gilardini L; Di Blasio AM; Invitti C
    Eur J Hum Genet; 2012 Dec; 20(12):1290-4. PubMed ID: 22643178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10.
    Krude H; Biebermann H; Schnabel D; Tansek MZ; Theunissen P; Mullis PE; Grüters A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4633-40. PubMed ID: 14557433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Cases With an Early Presented Proopiomelanocortin Deficiency-A Long-Term Follow-Up and Systematic Literature Review.
    Gregoric N; Groselj U; Bratina N; Debeljak M; Zerjav Tansek M; Suput Omladic J; Kovac J; Battelino T; Kotnik P; Avbelj Stefanija M
    Front Endocrinol (Lausanne); 2021; 12():689387. PubMed ID: 34177811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular screening of the proopiomelanocortin (POMC ) gene in Italian obese children: report of three new mutations.
    Miraglia del Giudice E; Cirillo G; Santoro N; D'Urso L; Carbone MT; Di Toro R; Perrone L
    Int J Obes Relat Metab Disord; 2001 Jan; 25(1):61-7. PubMed ID: 11244459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and Hyperphagia With Increased Defective ACTH: A Novel POMC Variant.
    van der Valk ES; Kleinendorst L; Delhanty PJD; van der Voorn B; Visser JA; van Haelst MM; de Graaff LCG; Huisman M; White A; Ito S; Wakamatsu K; de Rijke YB; van den Akker ELT; Iyer AM; van Rossum EFC
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3699-e3704. PubMed ID: 35737586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening of mutations in genes of pro-opiomelanocortin in patients with constitutional exogenous obesity].
    Pankov IuA; Iatsyshina SB; Karpova SK; Chekhranova MK; Popova IuP; Grigorian ON; Rogaev EI
    Vopr Med Khim; 2002; 48(1):121-30. PubMed ID: 12068494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the pro-opiomelanocortin gene in French obese children led to the identification of a novel deleterious heterozygous mutation located in the alpha-melanocyte stimulating hormone domain.
    Dubern B; Lubrano-Berthelier C; Mencarelli M; Ersoy B; Frelut ML; Bouglé D; Costes B; Simon C; Tounian P; Vaisse C; Clement K
    Pediatr Res; 2008 Feb; 63(2):211-6. PubMed ID: 18091355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity.
    Zemel MB; Shi H
    Nutr Rev; 2000 Jun; 58(6):177-80. PubMed ID: 10885325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight loss in obese children carrying the proopiomelanocortin R236G variant.
    Santoro N; Perrone L; Cirillo G; Raimondo P; Amato A; Coppola F; Santarpia M; D'Aniello A; Miraglia Del Giudice E
    J Endocrinol Invest; 2006 Mar; 29(3):226-30. PubMed ID: 16682835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.
    Ayers KL; Glicksberg BS; Garfield AS; Longerich S; White JA; Yang P; Du L; Chittenden TW; Gulcher JR; Roy S; Fiedorek F; Gottesdiener K; Cohen S; North KE; Schadt EE; Li SD; Chen R; Van der Ploeg LHT
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2601-2612. PubMed ID: 29726959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of POMC R236G mutation in Pakistan.
    Shabana ; Hasnain S
    Obes Res Clin Pract; 2016 Sep; 10 Suppl 1():S110-S116. PubMed ID: 26530524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children.
    Dubern B; Clément K; Pelloux V; Froguel P; Girardet JP; Guy-Grand B; Tounian P
    J Pediatr; 2001 Aug; 139(2):204-9. PubMed ID: 11487744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity.
    Pritchard LE; Turnbull AV; White A
    J Endocrinol; 2002 Mar; 172(3):411-21. PubMed ID: 11874690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the amino-terminal region of proopiomelanocortin (POMC) in patients with early-onset obesity impair POMC sorting to the regulated secretory pathway.
    Creemers JW; Lee YS; Oliver RL; Bahceci M; Tuzcu A; Gokalp D; Keogh J; Herber S; White A; O'Rahilly S; Farooqi IS
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4494-9. PubMed ID: 18697863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for beta-melanocyte-stimulating hormone in human body-weight regulation.
    Biebermann H; Castañeda TR; van Landeghem F; von Deimling A; Escher F; Brabant G; Hebebrand J; Hinney A; Tschöp MH; Grüters A; Krude H
    Cell Metab; 2006 Feb; 3(2):141-6. PubMed ID: 16459315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.